Marcel van den Brink: Microbiome research is now in “critical phase” where evidence points to therapeutic use

Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer

Top HHS officials last week called for a “moonshot” focused on the role of the microbiome in cancer.

May 22, 2026

How City of Hope is turning microbiome science into better cancer care

For years, clues pointed to the gut microbiome as a key factor in cancer treatment outcomes. Recent advances in gene sequencing are now clarifying its influence on how patients respond to therapy.

May 15, 2026

Vol.52 No.19

By Marcel van den Brink and Robert Jenq

In Brief

Robert Jenq named director of microbiome program at City of Hope

Robert R. Jenq was named director of the microbiome program at City of Hope and clinical professor in the Department of Hematology and Hematopoietic Cell Transplantation.

September 20, 2024

Vol.50 No.35

Clinical Roundup

Chemotherapy disrupts gut microbiome in patients with breast cancer

Chemotherapy is known to cause behavioral side effects, including cognitive decline. Notably, the gut microbiome communicates with the brain to affect behavior, including cognition.

July 12, 2024

Vol.50 No.28

Clinical Roundup

Changing gut microbiome improves outcomes for people newly diagnosed with metastatic kidney cancer in phase I study

People with metastatic kidney cancer who orally took a live biotherapeutic product called CBM588 while in treatment with immunotherapy and enzymatic tyrosine kinase inhibitors experienced improved health outcomes, according to research from City of Hope.

July 05, 2024

Vol.50 No.27

In Brief

Noam Auslander receives $600K grant to identify connections between gut microbial genes and melanoma immunotherapy

The Wistar Institute’s Noam Auslander, assistant professor in the Molecular and Cellular Oncogenesis Program at the Ellen and Ronald Caplan Cancer Center, was awarded a $600,000 Women Scientists Innovation Award for Cancer Research grant from the V Foundation for Cancer Research.

June 28, 2024

Vol.50 No.26

Marcel van den Brink: Microbiome research is now in “critical phase” where evidence points to therapeutic use

YOU MAY BE INTERESTED IN

Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer

How City of Hope is turning microbiome science into better cancer care

Robert Jenq named director of microbiome program at City of Hope

Chemotherapy disrupts gut microbiome in patients with breast cancer

Changing gut microbiome improves outcomes for people newly diagnosed with metastatic kidney cancer in phase I study

Noam Auslander receives $600K grant to identify connections between gut microbial genes and melanoma immunotherapy

Renew today!

Subscriber content

Never miss an issue!

Login